-
1 Comment
Shanghai Kehua Bio-Engineering Co.,Ltd is currently in a long term downtrend where the price is trading 0.3% below its 200 day moving average.
From a valuation standpoint, the stock is 75.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.4.
Shanghai Kehua Bio-Engineering Co.,Ltd's total revenue rose by 71.0% to $1B since the same quarter in the previous year.
Its net income has increased by 3686.3% to $209M since the same quarter in the previous year.
Finally, its free cash flow grew by 2964.7% to $429M since the same quarter in the previous year.
Based on the above factors, Shanghai Kehua Bio-Engineering Co.,Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE000001KC9 |
| PE Ratio | None |
|---|---|
| Target Price | 12.22 |
| Beta | 0.5 |
| Market Cap | 3B |
| Dividend Yield | None |
Shanghai Kehua Bio-Engineering Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sale of in vitro diagnostic reagents and medical testing equipment and services in China and internationally. The company offers immunoassay and clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management solution, and automated comprehensive solutions for nucleic acid blood screening. It also provides automatic modular and clinical chemistry analyzers and clinical chemistry reagents test menu; automatic chemiluminescence immunoassay analyzers and CLIA reagents test menu; automatic ELISA microplate readers, ELISA microplate washers, and enzyme-linked immunoassay reagents; and diagnostics kit for HIV and SARS-CoV-2 IgM/IgG antibody, HIV I/II Ab rapid tests, diagnostic kit for Hepatitis B surface antigen and Hepatitis C virus antibody, and diagnostic kit for antibody to T. Palladium. In addition, the company offers molecular diagnostics solutions, including fully automated nucleic acid blood screening laboratory solution and nucleic acid testing and detection kits; automatic multifunctional veterinary analyzer; and mass spectrometry. It exports its products. The company serves healthcare institutions, blood centers, disease control and prevention centers, and research organizations. Its products are used in clinical diagnostics, blood screening, public health, food safety, and scientific research applications. The company was founded in 1981 and is headquartered in Shanghai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002022.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
